14 results on '"Gerwen, M. van"'
Search Results
2. Verdrinkingsvallen zijn niet diervriendelijk
- Author
-
Gerwen, M. van, Ackermans, J., Gerwen, M. van, and Ackermans, J.
- Abstract
Kennis - Regelmatig lees je in de Nederlandse en Vlaamse media berichten over de inzet van zogenaamde ‘rattenhotels’ in de strijd tegen de rat. Sommige berichten geven de indruk dat de heilige graal is ontdekt met deze vallen. Ze zijn goed voor alles. Je kunt er effectief ratten mee bestrijden, er komt geen gif in het milieu terecht en ratten sterven pijnloos, zo klinkt het soms zelfs in de media. Rattenhotels zijn, anders dan de naam doet vermoeden, vallen waarin de ratten verdrinken.
- Published
- 2023
3. Natuurinclusieve plaagdierbeheersing
- Author
-
Gerwen, M. van, Mars, A., Gerwen, M. van, and Mars, A.
- Abstract
Natuurinclusief bouwen is in. In het kader van verduurzaming is het behoud en de ontwikkeling van biodiversiteit een belangrijk aandachtsgebied naast bijvoorbeeld energiebesparing. Bij natuurinclusief bouwen wordt er rekening gehouden met de aanwezigheid van planten en dieren en wordt die aanwezigheid gestimuleerd en benut.
- Published
- 2022
4. Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
- Author
-
Gerwen, M. van, Maggen, Charlotte, Cardonick, Elyce, Verwaaijen, Emma J., Heuvel-eibrink, Marry van den, Shmakov, Roman G., Ottevanger, P.B., Scarfone, Giovanna, Amant, Frederic, Gerwen, M. van, Maggen, Charlotte, Cardonick, Elyce, Verwaaijen, Emma J., Heuvel-eibrink, Marry van den, Shmakov, Roman G., Ottevanger, P.B., Scarfone, Giovanna, and Amant, Frederic
- Abstract
Contains fulltext : 234977.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
5. Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy
- Author
-
Maggen, C., Lok, C. A. R., Cardonick, E., Gerwen, M. van, Ottevanger, P.B., Boere, I.A., Koskas, M., Halaska, M.J., Fruscio, R., Gziri, M.M., Witteveen, P.O., Calsteren, K. van, Amant, F., Maggen, C., Lok, C. A. R., Cardonick, E., Gerwen, M. van, Ottevanger, P.B., Boere, I.A., Koskas, M., Halaska, M.J., Fruscio, R., Gziri, M.M., Witteveen, P.O., Calsteren, K. van, and Amant, F.
- Abstract
Contains fulltext : 218868.pdf (Publisher’s version ) (Open Access), INTRODUCTION: Gastric cancer during pregnancy is extremely rare and data on optimal treatment and possible chemotherapeutic regimens are scarce. The aim of this study is to describe the obstetric and maternal outcome of women with gastric cancer during pregnancy and review the literature on antenatal chemotherapy for gastric cancer. MATERIAL AND METHODS: Treatment and outcome of patients registered in the International Network on Cancer, Infertility and Pregnancy database with gastric cancer diagnosed during pregnancy were analyzed. RESULTS: In total, 13 women with gastric cancer during pregnancy were registered between 2002 and 2018. Median gestational age at diagnosis was 22 weeks (range 6-30 weeks). Twelve women were diagnosed with advanced disease and died within 2 years after pregnancy, most within 6 months. In total, eight out of 10 live births ended in a preterm delivery because of preeclampsia, maternal deterioration, or therapy planning. Two out of six women who initiated chemotherapy during pregnancy delivered at term. Two neonates prenatally exposed to chemotherapy were growth restricted and one of them developed a systemic infection with brain abscess after preterm delivery for preeclampsia 2 weeks after chemotherapy. No malformations were reported. CONCLUSIONS: The prognosis of gastric cancer during pregnancy is poor, mainly due to advanced disease at diagnosis, emphasizing the need for early diagnosis. Antenatal chemotherapy can be considered to reach fetal maturity, taking possible complications such as growth restriction, preterm delivery, and hematopoietic suppression at birth into account.
- Published
- 2020
6. Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
- Author
-
Vandenbroucke, T., Verheecke, M., Gerwen, M. van, Calsteren, K. van, Halaska, M.J., Fumagalli, M., Fruscio, R., Gandhi, A., Veening, M., Lagae, L., Ottevanger, P.B., Voigt, J.U., Haan, J de, Gziri, M.M., Maggen, C., Mertens, L., Naulaers, G., Claes, L., Amant, F., Vandenbroucke, T., Verheecke, M., Gerwen, M. van, Calsteren, K. van, Halaska, M.J., Fumagalli, M., Fruscio, R., Gandhi, A., Veening, M., Lagae, L., Ottevanger, P.B., Voigt, J.U., Haan, J de, Gziri, M.M., Maggen, C., Mertens, L., Naulaers, G., Claes, L., and Amant, F.
- Abstract
Contains fulltext : 225935.pdf (Publisher’s version ) (Open Access), BACKGROUND: Data on the long-term effects of prenatal exposure to maternal cancer and its treatment on child development are scarce. METHODS: In a multicenter cohort study, the neurologic and cardiac outcomes of 6-year-old children born to women diagnosed with cancer during pregnancy were compared with the outcome of children born after an uncomplicated pregnancy. Assessment included clinical evaluation, comprehensive neuropsychological testing, electrocardiography and echocardiography. RESULTS: In total, 132 study children and 132 controls were included. In the study group, 97 children (73.5%) were prenatally exposed to chemotherapy (alone or in combination with other treatments), 14 (10.6%) to radiotherapy (alone or in combination), 1 (0.8%) to trastuzumab, 12 (9.1%) to surgery alone and 16 (12.1%) to no treatment. Although within normal ranges, statistically significant differences were found in mean verbal IQ and visuospatial long-term memory, with lower scores in the study versus control group (98.1, 95% confidence interval [CI]: 94.5-101.8, versus 104.4, 95% CI: 100.4-108.4, P = 0.001, Q < 0.001 [Q refers to the false discovery rate adjusted P value], and 3.9, 95% CI: 3.6-4.3, versus 4.5, 95% CI: 4.1-4.9, P = 0.005, Q = 0.045, respectively). A significant difference in diastolic blood pressure was found, with higher values in chemotherapy-exposed (61.1, 95% CI: 59.0 to 63.2) versus control children (56.0, 95% CI 54.1 to 57.8) (P < 0.001, Q < 0.001) and in a subgroup of 59 anthracycline-exposed (61.8, 95% CI: 59.3 to 64.4) versus control children (55.9, 95% CI: 53.6 to 58.1) (P < 0.001, Q = 0.02). CONCLUSIONS: Children prenatally exposed to maternal cancer and its treatment are at risk for lower verbal IQ and visuospatial long-term memory scores and for higher diastolic blood pressure, but other cognitive functions and cardiac outcomes were normal at the age of 6 years. CLINICAL TRIAL REGISTRATION: The study is registered at ClinicalTrials.gov, NCT00330447.
- Published
- 2020
7. Stadsdier of natuurmens?! : CenSAS Dierendialoog
- Author
-
Gerwen, M. van and Gerwen, M. van
- Abstract
Wonen dieren in het leefgebied van mensen of is het andersom? Kun je wel spreken van aparte leefgebieden? Over deze vragen ging de tweede CenSAS Dierendialoog op 28 november 2019. Ruim honderd personen kwamen in Burgers’ Zoo bijeen om in gesprek te gaan over dieren in de natuur, in en om het huis en in de stad.
- Published
- 2020
8. Resultaten enquête dierenwelzijn in knaagdierbeheersing : Dierenwelzijn
- Author
-
Gerwen, M. van and Gerwen, M. van
- Abstract
In 2019 hield CenSAS een enquête over dierenwelzijn in knaagdierbeheersing. In dit artikel gaan we in op hoe plaagdierbeheersers denken over dierenwelzijn in hun werk. In het decembernummer van Pest Control News belichten we de afwegingen die in de praktijk worden gemaakt ten aanzien van dierenwelzijn en de dilemma’s die daarbij worden ervaren.
- Published
- 2020
9. CenSAS Dierendialoog 2019: stadsdier of natuurmens?!
- Author
-
Gerwen, M. van and Gerwen, M. van
- Abstract
Dieren zijn overal. Met miljoenen dieren in Nederland kom je ze overal tegen. Dat is vaak op plekken waar je ze verwacht, zoals in de natuur of in een dierentuin. Toch vinden we ook dieren op onverwachte plekken: wilde zwijnen in een woonwijk, muizen in je garage of een potvis op het strand. Juist op die plekken ontstaat vaak discussie.
- Published
- 2020
10. Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting
- Author
-
Amant, F. Berveiller, P. Boere, I.A. Cardonick, E. Fruscio, R. Fumagalli, M. Halaska, M.J. Hasenburg, A. Johansson, A.L.V. Lambertini, M. Lok, C.A.R. Maggen, C. Morice, P. Peccatori, F. Poortmans, P. Van Calsteren, K. Vandenbroucke, T. Van Gerwen, M. Van Den Heuvel-Eibrink, M. Zagouri, F. Zapardiel, I.
- Abstract
We aimed to provide comprehensive protocols and promote effective management of pregnant women with gynecological cancers. New insights and more experience have been gained since the previous guidelines were published in 2014. Members of the International Network on Cancer, Infertility and Pregnancy (INCIP), in collaboration with other international experts, reviewed existing literature on their respective areas of expertise. Summaries were subsequently merged into a manuscript that served as a basis for discussion during the consensus meeting. Treatment of gynecological cancers during pregnancy is attainable if management is achieved by collaboration of a multidisciplinary team of health care providers. This allows further optimization of maternal treatment, while considering fetal development and providing psychological support and long-term follow-up of the infants. Nonionizing imaging procedures are preferred diagnostic procedures, but limited ionizing imaging methods can be allowed if indispensable for treatment plans. In contrast to other cancers, standard surgery for gynecological cancers often needs to be adapted according to cancer type and gestational age. Most standard regimens of chemotherapy can be administered after 14 weeks gestational age but are not recommended beyond 35 weeks. C-section is recommended for most cervical and vulvar cancers, whereas vaginal delivery is allowed in most ovarian cancers. Breast-feeding should be avoided with ongoing chemotherapeutic, endocrine or targeted treatment. More studies that focus on the long-term toxic effects of gynecologic cancer treatments are needed to provide a full understanding of their fetal impact. In particular, data on targeted therapies that are becoming standard of care in certain gynecological malignancies is still limited. Furthermore, more studies aimed at the definition of the exact prognosis of patients after antenatal cancer treatment are warranted. Participation in existing registries (www.cancerinpregnancy.org) and the creation of national tumor boards with multidisciplinary teams of care providers (supplementary Box S1, available at Annals of Oncology online) is encouraged. © 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
- Published
- 2019
11. Voorwoord : Ook plaagdieren verdienen een verantwoorde behandeling
- Author
-
Gerwen, M. van and Gerwen, M. van
- Abstract
Duurzaam en verantwoord samenleven van mens en dier staat bij het Centre for Sustainable Animal Stewardship centraal. Een van de thema’s waar wij op dit moment onderzoek naar doen is de omgang met ratten en muizen die worden beschouwd als plaagdier. Wanneer dieren als zodanig worden gelabeld, lijken morele status en dierenwelzijn onbelangrijk te zijn.
- Published
- 2018
12. Nederland belemmerd do EG-recht by opleggen emigratieheffing?
- Author
-
Gerwen, M. van, Gerwen, M. van, Gerwen, M. van, and Gerwen, M. van
- Published
- 2005
13. Ecologische Focusgebieden: kans voor vergroening van het Europese landbouwbeleid
- Author
-
Gerwen, M. van and Gerwen, M. van
- Abstract
Begin 2014 treedt het nieuwe Gemeenschappelijk Landbouwbeleid (GLB) van de Europese Unie in werking. Een van de redenen om het GLB te wijzigen is de maatschappelijke vraag naar een landbouw die, naast productie, aandacht besteedt aan natuur en milieu. In het herziende GLB worden boeren verplicht vergroenende maatregelen te nemen, zoals ecologisch inrichten van land. Deze verplichte vergroening leidt tot veel ophef en discussie. De groene organisaties denken echter dat met name het verplicht inrichten van ecologische gebieden een kans is voor herstel van de soortenrijkdom op het platteland.
- Published
- 2012
14. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting.
- Author
-
Amant, F, Berveiller, P, Boere, I A, Cardonick, E, Fruscio, R, Fumagalli, M, Halaska, M J, Hasenburg, A, Johansson, A L V, Lambertini, M, Lok, C A R, Maggen, C, Morice, P, Peccatori, F, Poortmans, P, Calsteren, K Van, Vandenbroucke, T, Gerwen, M van, Heuvel-Eibrink, M van den, and Zagouri, F
- Subjects
- *
GYNECOLOGIC cancer , *MEDICAL personnel , *PREGNANCY , *HEALTH care teams , *VULVAR cancer , *PREGNANT women , *GYNECOLOGIC care , *GYNECOLOGIC surgery - Abstract
We aimed to provide comprehensive protocols and promote effective management of pregnant women with gynecological cancers. New insights and more experience have been gained since the previous guidelines were published in 2014. Members of the International Network on Cancer, Infertility and Pregnancy (INCIP), in collaboration with other international experts, reviewed existing literature on their respective areas of expertise. Summaries were subsequently merged into a manuscript that served as a basis for discussion during the consensus meeting. Treatment of gynecological cancers during pregnancy is attainable if management is achieved by collaboration of a multidisciplinary team of health care providers. This allows further optimization of maternal treatment, while considering fetal development and providing psychological support and long-term follow-up of the infants. Nonionizing imaging procedures are preferred diagnostic procedures, but limited ionizing imaging methods can be allowed if indispensable for treatment plans. In contrast to other cancers, standard surgery for gynecological cancers often needs to be adapted according to cancer type and gestational age. Most standard regimens of chemotherapy can be administered after 14 weeks gestational age but are not recommended beyond 35 weeks. C-section is recommended for most cervical and vulvar cancers, whereas vaginal delivery is allowed in most ovarian cancers. Breast-feeding should be avoided with ongoing chemotherapeutic, endocrine or targeted treatment. More studies that focus on the long-term toxic effects of gynecologic cancer treatments are needed to provide a full understanding of their fetal impact. In particular, data on targeted therapies that are becoming standard of care in certain gynecological malignancies is still limited. Furthermore, more studies aimed at the definition of the exact prognosis of patients after antenatal cancer treatment are warranted. Participation in existing registries (www.cancerinpregnancy.org) and the creation of national tumor boards with multidisciplinary teams of care providers (supplementary Box S1, available at Annals of Oncology online) is encouraged. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.